Page last updated: 2024-12-07

3-hydroxymandelic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Hydroxymandelic acid (3-HMA) is an aromatic alpha-hydroxy acid that has been investigated for its potential therapeutic benefits. It is a metabolite of L-dopa, a precursor to dopamine, and is found in various biological systems. 3-HMA has been shown to exhibit antioxidant and anti-inflammatory properties. Its synthesis is often achieved through chemical reactions involving mandelic acid as a starting material. Research on 3-HMA is driven by its potential role in neurological disorders, particularly Parkinson's disease, where it is believed to have neuroprotective effects. Furthermore, 3-HMA has been studied for its potential applications in the treatment of cancer and inflammatory conditions. The compound's ability to modulate dopamine levels and its antioxidant properties make it a promising target for further research in the development of novel therapeutic agents.'

3-hydroxymandelic acid : A 2-hydroxy monocarboxylic acid that is mandelic acid substituted by a hydroxy group at position 3'. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID86957
CHEBI ID86553
SCHEMBL ID1840382
MeSH IDM0081931

Synonyms (42)

Synonym
m-hydroxymandelic acid
17119-15-2
3-hydroxymandelic acid, >=97.0% (t)
3-hydroxymandelic acid
BMSE000573
dl-hydroxy(m-hydroxyphenyl)acetic acid
alpha,3-dihydroxybenzeneacetic acid
hydroxy(3-hydroxyphenyl)acetic acid
3-hydroxyphenylglycolic acid
2-hydroxy-2-(3-hydroxyphenyl)acetic acid
A811304
AKOS009157988
einecs 241-182-3
537k5qmu5f ,
unii-537k5qmu5f
meta-hydroxymandelic acid
FT-0615846
mhma
SCHEMBL1840382
mandelic acid, m-hydroxy-
hydroxy(3-hydroxyphenyl)acetic acid #
3-hydroxymandelate
3-hydroxymandelic acid, (+/-)-
2-hydroxy-2-(3-hydroxyphenyl)ethanoic acid
CHEBI:86553
AS-64759
mfcd00042723
J-010698
m-hydroxy-(6ci,7ci,8ci)mandelate
m-hydroxy-(6ci,7ci,8ci)mandelic acid
m-hydroxymandelate
dl-3-hydroxymandelate
HY-W015326
CS-W016042
DTXSID70864737
Q10395567
(+/-)-3-hydroxymandelic acid
2-hydroxy-2-(3-hydroxyphenyl)aceticacid
3-hydroxymandelicacid
SB85224
benzeneacetic acid, ?,3-dihydroxy-
PD099469

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" When m-synephrine hydrochloride was administered orally to humans in normal dosage regimens four main metabolites were excreted in urine: (i) unconjugated m-hydroxymandelic acid (MHMA, 30%), (ii) m-hydroxyphenylglycol (MHPG) sulphate (6%), (iii) m-synephrine sulphate (47%) and (iv) m-synephrine glucuronide (12%)."( The mammalian metabolism of R-(-)-m-synephrine.
Crowley, JR; Ibrahim, KE; Midgley, JM; Williams, CM, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
2-hydroxy monocarboxylic acid
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (70.00)18.7374
1990's3 (30.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.31 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index17.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]